GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbury Ltd (NSE:WANBURY) » Definitions » Valuation Rank

Wanbury (NSE:WANBURY) Valuation Rank


View and export this data going back to 2007. Start your Free Trial

What is Wanbury Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Wanbury Valuation Rank Related Terms

Thank you for viewing the detailed overview of Wanbury's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Wanbury Business Description

Traded in Other Exchanges
Address
BSEL Techpark, B Wing, 10th Floor, Sector 30-A, Opposite Vashi Railway Station, Vashi, Navi Mumbai, MH, IND, 400703
Wanbury Ltd is engaged in the business of pharmaceutical and related activities including research. Some of the company products are Cpink 50mg table, Rabiplus capsules, Folinine softule, etc. The company has one segment of activity namely Pharmaceuticals. It generates revenue from a contract with customers from the sale of manufactured and traded goods. Geographically, key revenue is generated from outside India.